Keywords
Last Name
Institution
Children's Mercy Kansas City
More Search Options
Menu
Home
Find People
Find Everything
About This Site
Annual Report
Export RDF
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.
Nishikawa S, Iwakuma T. Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials. Cancers (Basel). 2023 Jan 09; 15(2).
View in:
PubMed
authors with profiles
Tomoo Iwakuma
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.